Certified by Founder Lodge
Syncona Limited
United Kingdom - London, England
INVESTOR
1 Disclosed Funding Rounds $28,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Syncona, is a leading FTSE 250 healthcare company focused on creating, building and scaling a portfolio of global leaders in life science.
Our vision is to build a sustainable, diverse por
| Company | Date | Round | Raised |
|---|---|---|---|
Mosaic TX |
April, 05 ,2023 | Series A | $28,000,000 |
Beacon Therapeutics |
July, 10 ,2024 | Series B | $170,000,000 |
Resolution Therapeutics |
October, 03 ,2024 | Unknown | $83,383,437 |
Mosaic TX
Beacon Therapeutics
Resolution Therapeutics
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)